Brigitte Tenni
Biographic Data
| ID | 6678717 |
|---|---|
| NAME | Brigitte Tenni |
| GIVEN NAMES | Brigitte |
| FAMILY NAME | Tenni |
| SIGNATURE | TENNI B |
| AFFILIATIONS | The University of Melbourne |
| ORCID | 0000-0002-3356-4967 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 8 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Protecting Access to Medicines After Cambodia Graduates From Least Developed Country Status
Cambodia is a least developed country (LDC); however, it may graduate from the LDC status by 2029 Membership in the World Trade Organisation, will require Cambodia to provide patent protection for medicines that meet standard criteria. This qualitative policy analysis examines Cambodia's readiness for LDC graduation in terms of protecting access to medicines and explores how it can prepare to mitigate the impact of graduation on access to medicin…
The potential impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on Thailand’s hepatitis C treatment program
BACKGROUND: Thailand has expressed interest in joining the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), a twelve-country plurilateral trade agreement whose original incarnation included the United States of America (USA). When the USA withdrew from this agreement, key intellectual property clauses relevant to pharmaceuticals were suspended. These could be reinstated should the CPTPP Parties decide to do so. METHO…
Global inequities in access to Covid-19 health products and technologies
This paper presents a political economy analysis of global inequities in access to COVID-19 vaccines, treatments, and diagnostic tests. We adapt a conceptual model used for analysing the political economy of global extraction and health to examine the politico-economic factors affecting access to COVID-19 health products and technologies in four interconnected layers: the social, political, and historical context; politics, institutions, and poli…
What is the impact of intellectual property rules on access to medicines? A systematic review
The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam
In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA successfully pursued intellectual property (IP) provisions that will affect the affordability of medicines, including anti-retrovirals (ARV) for HIV. Vietnam has the lowest GDP per capita of the 12 TPP countries and in 2013 provided ARVs for only 68% of eligible people living with HIV. Using the current Vietnamese IP regime as our base case, we analysed the potential impact of…
Global inequities in access to Covid-19 health products and technologies
This paper presents a political economy analysis of global inequities in access to COVID-19 vaccines, treatments, and diagnostic tests. We adapt a conceptual model used for analysing the political economy of global extraction and health to examine the politico-economic factors affecting access to COVID-19 health products and technologies in four interconnected layers: the social, political, and historical context; politics, institutions, and poli…
The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam
In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA successfully pursued intellectual property (IP) provisions that will affect the affordability of medicines, including anti-retrovirals (ARV) for HIV. Vietnam has the lowest GDP per capita of the 12 TPP countries and in 2013 provided ARVs for only 68% of eligible people living with HIV. Using the current Vietnamese IP regime as our base case, we analysed the potential impact of…
What is the impact of intellectual property rules on access to medicines? A systematic review
Global inequities in access to Covid-19 health products and technologies
This paper presents a political economy analysis of global inequities in access to COVID-19 vaccines, treatments, and diagnostic tests. We adapt a conceptual model used for analysing the political economy of global extraction and health to examine the politico-economic factors affecting access to COVID-19 health products and technologies in four interconnected layers: the social, political, and historical context; politics, institutions, and poli…
The potential impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on Thailand’s hepatitis C treatment program
BACKGROUND: Thailand has expressed interest in joining the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), a twelve-country plurilateral trade agreement whose original incarnation included the United States of America (USA). When the USA withdrew from this agreement, key intellectual property clauses relevant to pharmaceuticals were suspended. These could be reinstated should the CPTPP Parties decide to do so. METHO…
Protecting Access to Medicines After Cambodia Graduates From Least Developed Country Status
Cambodia is a least developed country (LDC); however, it may graduate from the LDC status by 2029 Membership in the World Trade Organisation, will require Cambodia to provide patent protection for medicines that meet standard criteria. This qualitative policy analysis examines Cambodia's readiness for LDC graduation in terms of protecting access to medicines and explores how it can prepare to mitigate the impact of graduation on access to medicin…
Economics (4 works) · Medicine (4 works) · Political science (4 works) · Business (3 works) · Economic growth (3 works) · Law (3 works) · Pharmaceutical Economics and Policy (3 works) · General partnership (2 works) · Global Public Health Policies and Epidemiology (2 works) · Intellectual property (2 works)